These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Distribution of medicine in daily dose packages to psychiatric patients]. Bratberg S Tidsskr Nor Laegeforen; 1973 May; 93(13):954-5. PubMed ID: 4751596 [No Abstract] [Full Text] [Related]
6. [Study of the injectable form of dipotassic clorazepate in the psychiatric hospital]. Lambert PA; Bouchardy M J Med Lyon; 1971 May; 52(208):763-71. PubMed ID: 5138670 [No Abstract] [Full Text] [Related]
7. [Analysis of more than 1000 cases treated with Esucos from 1959 to 1965]. Burton P; Arnould F; Paquay J; Tinant M Brux Med; 1967 Feb; 47(9):215-35. PubMed ID: 5600791 [No Abstract] [Full Text] [Related]
8. [Drug therapy of psychiatric disorders in general practice]. Lingjaerde O Tidsskr Nor Laegeforen; 1969 Jun; 89(11):Suppl:907-11. PubMed ID: 5792130 [No Abstract] [Full Text] [Related]
9. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data]. Mormont C Acta Psychiatr Belg; 1972 Sep; 72(5):595-601. PubMed ID: 4669431 [No Abstract] [Full Text] [Related]
10. [Changes in peripheral blood during treatment with some neuroleptics and thymoleptics]. Kiczak J; Warnecka-Przybylska M; Wdowiak MW Psychiatr Pol; 1975; 9(3):275-81. PubMed ID: 1153559 [No Abstract] [Full Text] [Related]
12. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients. Douglas KW; Hindley JP; Kerin MT Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590 [No Abstract] [Full Text] [Related]
13. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics]. Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657 [No Abstract] [Full Text] [Related]
14. [Value of long-acting (so-called delayed-action or sustained-release) neuroleptics]. Bobon DP Rev Med Liege; 1972 Oct; 27(20):684-8. PubMed ID: 5073063 [No Abstract] [Full Text] [Related]
15. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions]. Gayral L; Escande M; Fournié H; Perretti A Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751 [No Abstract] [Full Text] [Related]
16. Polypharmacy in psychiatric treatment. Physician's treatment preference and practice survey. Merlis S; Fracchia J; Sheppard C N Y State J Med; 1972 Aug; 72(15):1944-7. PubMed ID: 4403332 [No Abstract] [Full Text] [Related]
17. [Experience with long-acting depot--neuroleptics in schizophrenic psychoses]. Taussigová D; Prokopová Z; Bastecký J; Vinar O Act Nerv Super (Praha); 1973 May; 15(2):83-4. PubMed ID: 4752675 [No Abstract] [Full Text] [Related]
18. [Behavior of some serum enzyme activity in the course of treatment with neuroleptics and thymoleptics]. Kiczak J; Sliwińska-Przyjemska H; Warnecka--Przybylska M; Wdowiak MW Psychiatr Pol; 1976; 10(2):153-7. PubMed ID: 1273160 [No Abstract] [Full Text] [Related]
19. [On the neuroleptics Atosil and Aolept in child psychiatric practice of rural district hospitals]. Jacobs R Prax Kinderpsychol Kinderpsychiatr; 1969; 18(4):149-52. PubMed ID: 4389480 [No Abstract] [Full Text] [Related]
20. [Neuroleptic treatment of prisoners with mental abnormalities]. Lech-Sobczak A Psychiatr Pol; 1972; 6(5):563-7. PubMed ID: 5083341 [No Abstract] [Full Text] [Related] [Next] [New Search]